Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biocompatibility issues in hemodialysis.

R Vanholder1

  • 1Nephrology Department, University Hospital, Ghent, Belgium.

Clinical Materials
|December 10, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney health for all: caring for people, protecting the planet.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same author

Wars and kidney patients: a statement by the European Kidney Health Alliance related to the Russian-Ukrainian conflict.

Journal of nephrology·2022
Same author

Treating potassium disturbances: kill the killers but avoid overkill.

Acta clinica Belgica·2018
Same author

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to measure creatinine in human urine.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2015
Same author

AKI in early sepsis is a continuum from transient AKI without tubular damage over transient AKI with minor tubular damage to intrinsic AKI with severe tubular damage.

International urology and nephrology·2014
Same author

The paradox of bardoxolone methyl: a call for every witness on the stand?

Diabetes, obesity & metabolism·2014
Same journal

Product liability implications of biomaterials in the United States.

Clinical materials·1993
Same journal

Biocompatibility evaluation of laser-induced AAm and HEMA grafted EPR. Part 1: In-vitro study.

Clinical materials·1993
Same journal

Early effects of the self-reinforced PGA implant on a growing bone: an experimental study on growing rats.

Clinical materials·1993
Same journal

Bone formation and remodeling around implanted materials under load-bearing conditions.

Clinical materials·1993
Same journal

The effects of lactic acid on PGE2 production by macrophages and human synovial fibroblasts: a possible explanation for problems associated with the degradation of poly(lactide) implants?

Clinical materials·1993
Same journal

Glassy carbon implant as a bone graft substitute: an experimental study on rabbits.

Clinical materials·1993
See all related articles

Hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) involve blood contact with foreign materials, leading to unavoidable biocompatibility issues. This review details eight major problems and their clinical implications, exploring prevention strategies and future directions for improved patient outcomes.

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Clinical Medicine

Background:

  • Hemodialysis and CAPD are essential treatments for uremic patients, requiring repeated blood-material interactions.
  • Historically, the focus was on toxin removal, but biocompatibility issues have emerged as significant morbid concerns.
  • Both hemodialysis and CAPD present unique biocompatibility challenges impacting patient health.

Purpose of the Study:

  • To comprehensively review the biocompatibility problems associated with dialysis treatments.
  • To discuss eight major issues arising from blood-material interactions in hemodialysis and CAPD.
  • To explore the biochemical and clinical implications of these biocompatibility challenges.

Main Methods:

  • Review of recent findings on dialysis-related biocompatibility issues.

Related Experiment Videos

  • Discussion of eight specific problems: coagulation, complement/leukocyte activation, infection, leaching, surface alterations, allergies, shear, and dialysate contamination.
  • Analysis of biochemical and clinical implications.

    • Main Results:

    • Identified eight key biocompatibility problems in dialysis, including coagulation, immune activation, infection risk, material degradation, and allergic reactions.
    • Highlighted the significant morbid implications of these issues for patients undergoing renal replacement therapy.
    • Emphasized the need to address biocompatibility beyond mere toxin elimination.

    Conclusions:

    • Biocompatibility remains a critical challenge in hemodialysis and CAPD, necessitating careful material selection and management.
    • Understanding and mitigating the eight identified problems are crucial for preventing morbidity in dialysis patients.
    • Future research should focus on developing more biocompatible materials and strategies to improve long-term patient outcomes.